High seroprevalence of anti-HTLV-I/II antibodies among solid organ donors necessitates confirmatory testing

Transplantation

Volumn 82, Issue 9, 2006, Pages 1210-1213

  Nowicki, Marek J ^a   Matsuoka, Lea ^a,b   Brucal, Dem ^a   Chinchilla, Claudia ^a   Mone, Thomas ^c   Selby, Rick ^b   Mendez, Robert ^a  

^a National Institute of Transplantation Los Angeles   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c OneLegacy Transplant Donor Network   (United States)

Author keywords

Human T cell lymphotrophic virus; Organ transplantation; Viral infection

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; HUMAN T CELL LYMPHOTROPHIC VIRUS TYPE 1 ANTIBODY; HUMAN T CELL LYMPHOTROPHIC VIRUS TYPE 2 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; MALE; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SAMPLING; SEROPREVALENCE; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; FEMALE; HTLV-I ANTIBODIES; HTLV-II ANTIBODIES; HUMANS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; TISSUE DONORS;

EID: 33750982116     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000236031.03510.75     Document Type: Article

References (16)

1. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353(9168): 1951.
2. Shames BD, D'Allessandro AM, Sollinger HW. Human T-cell lymphotrophic virus infection in organ donors: A need to reassess policy? Am J Transplant 2002; 2(7): 658.
3. Gonzalez-Perez MP, Munoz-Juarez L, Cadenas FC, et al. Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor. Transplantation 2003; 75(7): 1006.
4. Gout O, Baulac M, Gessain A, et al. Rapid Development of Myelopathy After HTLV-I Infection Acquired by Transfusion During Cardiac Transplantation. N Engl J Med 1990; 322(6): 383.
5. Remesar MC, del Pozo AE, Pittis MG, et al. Transmission of HTLV-I by kidney transplant. Transfusion 2000; 40(11): 1421.
6. Toro C, Rodes B, Poveda E, Soriano V. Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation 2003; 75(1): 102.
7. Donegan E, Busch MP, Galleshaw JA, et al. Transfusion of blood components from a donor with human T-lymphotropic virus type II (HTLV-II) infection. The Transfusion Safety Study Group. Ann Intern Med 1990; 113(7): 555.
8. Donegan E, Lee H, Operskalski EA, et al. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion 1994; 34(6): 478.
9. Operskalski EA, Schiff ER, Kleinman SH, et al. Epidemiologic background of blood donors with antibody to human T-cell lymphotropic virus. Transfusion Safety Study Group. Transfusion 1989; 29(8): 746.
10. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334(26): 1685.
11. Kauffman HM, Taranto SE. Human T-cell lymphotrophic virus type-1 and organ donors. Transplantation 2003; 76(4): 745.
12. Domen RE, Nelson KA. Results of a survey of infectious disease testing practices by organ procurement organizations in the United States. Transplantation 1997; 63(12): 1790.
13. Tanabe K, Kitani R, Takahashi K, et al. Long-term results in human T-cell leukemia virus type 1-positive renal transplant recipients. Transplant Proc 1998; 30(7): 3168.
14. Lu SC, Chen BH. Seroindeterminate HTLV-1 prevalence and characteristics in blood donors in Taiwan. Int J Hematol 2003; 77(4): 412.
15. Zou SM, Dodd RY, Stramer SL, Strong DM. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 2004; 351(8): 751.
16. Available at: www.optn.org. Accessed December 7, 2005.